Crystal structure of human nicotinic acid phosphoribosyltransferase
Nicotinic acid phosphoribosyltransferase (EC 2.4.2.11) (NaPRTase) is the rate‐limiting enzyme in the three‐step Preiss–Handler pathway for the biosynthesis of NAD. The enzyme catalyzes the conversion of nicotinic acid (Na) and 5‐phosphoribosyl‐1‐pyrophosphate (PRPP) to nicotinic acid mononucleotide...
Main Authors: | Ada Serena Marletta, Alberto Massarotti, Giuseppe Orsomando, Giulio Magni, Menico Rizzi, Silvia Garavaglia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1016/j.fob.2015.05.002 |
Similar Items
-
Metabolic Alterations in NADSYN1-Deficient Cells
by: Nils W. F. Meijer, et al.
Published: (2023-12-01) -
Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors
by: Jorge Franco, et al.
Published: (2022-07-01) -
Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators
by: Cecilia Baldassarri, et al.
Published: (2023-01-01) -
The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth
by: Kishor Pant, et al.
Published: (2023-02-01) -
NAMPT inhibition relieves intestinal inflammation by regulating macrophage activation in experimental necrotizing enterocolitis
by: Qianyang Liu, et al.
Published: (2023-09-01)